Network origin in John Connolly first degree
Entity | Entity type | Industry | |
---|---|---|---|
Rna Diagnostics, Inc.
Rna Diagnostics, Inc. Medical SpecialtiesHealth Technology Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada.
6
| Holding Company | Medical Specialties | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John Connolly via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Select Therapeutics, Inc.
Select Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Select Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is focused on the development of cell based therapeutics production. The company was founded by Clifford A. Lingwood in January 1997 and is headquartered in Brookline, MA. | Pharmaceuticals: Generic | Director/Board Member | |
LUMINEX CORPORATION | Medical Specialties | Chief Tech/Sci/R&D Officer | |
CARERX CORPORATION | Medical/Nursing Services | Director/Board Member | |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Private Equity Investor | |
Eli Lilly Canada, Inc.
Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Canada, Inc. is a healthcare leader that focuses on oncology, diabetes, autoimmunity, neurodegeneration, and pain. The company is based in Scarborough, Canada. Established in 1938, the Canadian company collaborates with scientists to produce innovative medicines that make life better for people around the world. The company's mission is to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to communities through philanthropy and volunteerism. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BDC Venture Capital
BDC Venture Capital Investment ManagersFinance BDC Venture Capital (BDC Venture Capital) is a venture capital firm founded in 1975. The firm is headquartered in Québec, Canada. | Investment Managers | Head-Equity Investments | |
Queen's University | College/University | Graduate Degree Undergraduate Degree | |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
University of Toronto | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
University of Western Ontario | College/University | Masters Business Admin | |
McMaster University | College/University | Undergraduate Degree | |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | Information Technology Services | Director/Board Member | |
Luminex Molecular Diagnostics, Inc.
Luminex Molecular Diagnostics, Inc. Medical/Nursing ServicesHealth Services Luminex Molecular Diagnostics, Inc. develops DNA based diagnostics tests and software solutions, which include genetic tests for disorders, drug metabolism and infectious diseases. The firm’s products include P450-2D6, P450-2C9, P450-2C19, AJ panel and CFTR. The company was founded in March 2007 and is headquartered in Toronto, Canada. | Medical/Nursing Services | Corporate Officer/Principal Chairman | |
Canada's Research Based Pharmaceutical Cos. | Chairman | ||
Allergen NCE, Inc.
Allergen NCE, Inc. Miscellaneous Commercial ServicesCommercial Services Allergen NCE, Inc.is a national research network, seeking asthma and allergy treatment from a naturopath. It invests in training the next generation of researchers, innovators and clinician-scientists. The company was founded in 2004 and is headquartered in Hamilton, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Pharmaceutical Manufacturers Association of Canada | Director/Board Member | ||
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Chairman | |
Ontario Genomics Institute | Director/Board Member | ||
ECOSYNTHETIX INC. | Chemicals: Specialty | Chairman | |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Montreal Invivo Organization | Director/Board Member | ||
Life Sciences Ontario | Chairman | ||
The University of Toronto Mississauga | College/University | Corporate Officer/Principal | |
The Directors College | College/University | Undergraduate Degree | |
Relentless Pursuit Partners, Inc.
Relentless Pursuit Partners, Inc. Investment ManagersFinance Founded by Simon Whitfield and Brenda Irwin in 2014, Relentless Pursuit Partnrs Inc is a venture capital firm headquartered in Canada. | Investment Managers | Consultant / Advisor | |
ABcann Medicinals, Inc.
ABcann Medicinals, Inc. Pharmaceuticals: MajorHealth Technology ABcann Medicinals, Inc. operates medical marijuana producer. It offers chemical free grown in soil pesticide free pharmaceutical graded products. The firm provides organic standardized medical cannabis. The company was founded by Ken Clement and is headquartered in Napanee, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Induran Ventures, Inc. | Chairman | ||
Proteocyte Diagnostics, Inc.
Proteocyte Diagnostics, Inc. Medical SpecialtiesHealth Technology Proteocyte Diagnostics, Inc. develops prognostic oral precancer laboratory, which objectively and accurately detects oral lesions. The company was founded in 2011 and is headquartered in Toronto, Canada. | Medical Specialties | Director of Finance/CFO | |
VIVO CANNABIS INC. | Agricultural Commodities/Milling | Chairman | |
Strategic Regional Research Alliance | Director/Board Member |
Statistics
International
Canada | 34 |
United States | 4 |
Sectoral
Health Technology | 10 |
Consumer Services | 7 |
Commercial Services | 6 |
Finance | 4 |
Health Services | 3 |
Operational
Director/Board Member | 21 |
Chairman | 9 |
Corporate Officer/Principal | 6 |
Undergraduate Degree | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Most connected contacts
Insiders | |
---|---|
Paul Lucas | 24 |
Denis Ho | 9 |
Jeremy K. Bridge-Cook | 8 |
Kenneth P. H. Pritzker | 2 |
John Jordan | 2 |
Laura Pritzker | 2 |
- Stock Market
- Insiders
- John Connolly
- Company connections